ArticleJournal of clinical pharmacology2024

A Randomized, Parallel, Open-Label, Single-Dose and Multiple-Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China.

Jing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.